Microbial pathogenesisAntitubercular AgentsHumansMycobacterium tuberculosisTuberculosisMultidrug-Resistant
Clinical perspective of multiple drug resistance tuberculosis: An overview.
Arpit Raj, Vikrant Abbot, Kapil Kumar
Published: 202510.1016/j.micpath.2025.108115
Abstract
The rational drug design and development of new medication requires an appropriate understanding of the pharmacokinetics and pharmacodynamics of anti-TB drugs. Nevertheless, the implementation and processing of drugs were not quite effective at the e…
Preview only. Read the full abstract at the source